Drawing for SCI SCIENTIFIC COMMUNICATIONS & INFORMATION

USPTO serial 87255028

SCI SCIENTIFIC COMMUNICATIONS & INFORMATION

Reviewed by CopyMark Law Group

Reg. 5333250Status 710
Filing date
Status date
Registration date
Nov 14, 2017
Examiner
MICHOS, JOHN E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with SCI SCIENTIFIC COMMUNICATIONS & INFORMATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey C. Katz

JEFFREY C. KATZ DAVIS & GILBERT LLP1740 BROADWAYNEW YORK, NY 10019UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business marketing consulting services in the field of pharmaceuticals, biotechnology, clinical trials and medical affairs; providing market research and market data analytics in the field of pharmaceuticals, biotechnology, disease awareness, clinical trials and medical affairs; lobbying services, namely, promoting the interests of pharmaceutical and biotechnology enterprises in the fields of legislation and medical affairs; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting and management in the field of clinical trials, namely, providing information management services; recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; providing independent review of clinical trials for business purposesSECTION 8 - CANCELLED—
041Consulting services relating to the publication of newsletters, manuscripts, articles, posters, abstracts, reports, white papers, tip sheets, books, ebooks and podium presentations in the field of medical education and researchSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 28, 2024C8..CANCELLED SEC. 8 (6-YR)—
Nov 14, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 14, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 29, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 29, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 9, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 17, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 29, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 28, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 28, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 28, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 20, 2016DOCKASSIGNED TO EXAMINER—
Dec 8, 2016MPMKNOTICE OF PSEUDO MARK E-MAILED—
Dec 7, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 6, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance